BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Hu X, Pan T, Dong L, Ding L, Wang Z, Song R, Wang X, Wang N, Zhang Y, Wang J, Yang B. Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway. Biomed Pharmacother 2021;133:110802. [PMID: 33202286 DOI: 10.1016/j.biopha.2020.110802] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Sun X, Abulizi A, Xu J, He Y, Chen Q, Yan R. Effects of salvianolic acid A on intestinal microbiota and lipid metabolism disorders in Zucker diabetic fatty rats. Diabetol Metab Syndr 2022;14:135. [PMID: 36127704 DOI: 10.1186/s13098-022-00868-z] [Reference Citation Analysis]
2 He H, Liu M, He R, Zhao W. Lipid-lowering activity of metformin-soluble soybean polysaccharide nanoparticles. Food Funct 2022. [PMID: 36125039 DOI: 10.1039/d2fo01237e] [Reference Citation Analysis]
3 Liu T, Zhang N, Kong L, Chu S, Zhang T, Yan G, Ma D, Dai J, Ma Z. Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK/AMPK pathway. Front Pharmacol 2022;13:968717. [DOI: 10.3389/fphar.2022.968717] [Reference Citation Analysis]
4 Xiao X, Luo Y, Peng D. Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism. Front Cardiovasc Med 2022;9:879355. [DOI: 10.3389/fcvm.2022.879355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li HM, Liu X, Meng ZY, Wang L, Zhao LM, Chen H, Wang ZX, Cui H, Tang XQ, Li XH, Han WN, Bai X, Lin Y, Liu H, Zhang Y, Yang BF. Kanglexin delays heart aging by promoting mitophagy. Acta Pharmacol Sin 2022;43:613-23. [PMID: 34035486 DOI: 10.1038/s41401-021-00686-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
6 Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, Ertas YN, Mirzaei S, Samarghandian S. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomed Pharmacother 2022;146:112563. [PMID: 35062059 DOI: 10.1016/j.biopha.2021.112563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
7 Varghese R, George Priya Doss C, Kumar RS, Almansour AI, Arumugam N, Efferth T, Ramamoorthy S. Cardioprotective effects of phytopigments via multiple signaling pathways. Phytomedicine 2021;95:153859. [PMID: 34856476 DOI: 10.1016/j.phymed.2021.153859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tombling BJ, Zhang Y, Huang YH, Craik DJ, Wang CK. The emerging landscape of peptide-based inhibitors of PCSK9. Atherosclerosis 2021;330:52-60. [PMID: 34246818 DOI: 10.1016/j.atherosclerosis.2021.06.903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Du H, Li C, Wang Z, He Y, Wang Y, Zhou H, Wan H, Yang J. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats. J Ethnopharmacol 2021;274:114058. [PMID: 33766756 DOI: 10.1016/j.jep.2021.114058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Luquero A, Badimon L, Borrell-Pages M. PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation. Front Cardiovasc Med 2021;8:639727. [PMID: 33834043 DOI: 10.3389/fcvm.2021.639727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
11 Liu X, Han W, An N, Cao N, Wu T, Yang S, Ding L, Chen X, Chen C, Aruhan, Zhang Y, Wang K, Suo L, Huang J, Wang J, Zhao X, Zhu J, Zhang Y, Yang B. Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway. Front Pharmacol 2020;11:572637. [PMID: 33519438 DOI: 10.3389/fphar.2020.572637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]